Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells. | Cells | 2023 | 37443801 | PubTator, text mining | PubMed |
| Epigenetic marks associated with gestational diabetes mellitus across two time points during pregnancy. | Clin Epigenetics | 2023 | 37415231 | PubTator, text mining | PubMed |
| PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain. | Genes Dis | 2023 | 37397533 | PubTator, text mining | PubMed |
| Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy. | Front Oncol | 2023 | 37397394 | PubTator, text mining | PubMed |
| Downregulation of SODD mediates carnosol-induced reduction in cell proliferation in esophageal adenocarcinoma cells. | Sci Rep | 2023 | 37386230 | PubTator, text mining | PubMed |
| Exosome-delivered circRPS5 inhibits the progression of melanoma via regulating the miR-151a/NPTX1 axis. | PLoS One | 2023 | 37384727 | PubTator, text mining | PubMed |
| Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function. | J Exp Med | 2023 | 37382881 | PubTator, text mining | PubMed |
| Plant-Derived Nutraceuticals Involved in Body Weight Control by Modulating Gene Expression. | Plants (Basel) | 2023 | 37375898 | PubTator, text mining | PubMed |
| Genetics: A Starting Point for the Prevention and the Treatment of Obesity. | Nutrients | 2023 | 37375686 | PubTator, text mining | PubMed |
| Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity. | Cancer Res | 2023 | 37339176 | PubTator, text mining | PubMed |
| Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. | Front Oncol | 2023 | 37333810 | PubTator, text mining | PubMed |
| Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC). | Cell Mol Gastroenterol Hepatol | 2023 | 37331566 | PubTator, text mining | PubMed |
| Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full-length protein. | Sci Signal | 2023 | 37311034 | PubTator, text mining | PubMed |
| High GLI-1 Expression is a Reliable Indicator of Bad Prognosis in Newly Diagnosed Acute Leukemia Patients. | Indian J Hematol Blood Transfus | 2023 | 37304485 | PubTator, text mining | PubMed |
| Effectiveness of Albumin-Fused Thioredoxin against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro. | Int J Mol Sci | 2023 | 37298708 | PubTator, text mining | PubMed |
| Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration. | Front Pharmacol | 2023 | 37274099 | PubTator, text mining | PubMed |
| Normalizing Input-Output Relationships of Cancer Networks for Reversion Therapy. | Adv Sci (Weinh) | 2023 | 37269056 | PubTator, text mining | PubMed |
| Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. | Nature | 2023 | 37258666 | PubTator, text mining | PubMed |
| The joint role of methylation and immune-related lncRNAs in ovarian cancer: Defining molecular subtypes and developing prognostic signature. | Transl Oncol | 2023 | 37257331 | PubTator, text mining | PubMed |
| Structural insights into regulation of CCN protein activities and functions. | J Cell Commun Signal | 2023 | 37245184 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=11